Use of antiviral drugs for seasonal influenza: Foundation document for practitioners-Update 2019

J Assoc Med Microbiol Infect Dis Can. 2019 Jun 17;4(2):60-82. doi: 10.3138/jammi.2019.02.08. eCollection 2019 Jun.

Fred Y Aoki¹, Upton D Allen^{2

3

4}, Samira Mubareka⁵, Jesse Papenburg^{6

7}, H Grant Stiver⁸, Gerald A Evans⁹

¹ Medical Microbiology and Pharmacology & Therapeutics, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
² Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
³ Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
⁴ Division of Infectious Diseases, Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.
⁵ Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
⁶ Division of Pediatric Infectious Diseases, Department of Pediatrics, Montreal Children's Hospital, McGill University Health Centre, Montréal, Québec, Canada.
⁷ Division of Microbiology, Department of Clinical Laboratory Medicine, Montreal Children's Hospital, McGill University Health Centre, Montréal, Québec, Canada.
⁸ Division of Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
⁹ Division of Infectious Diseases, Department of Medicine, Kingston Health Sciences Centre, Queen's University, Kingston, Ontario, Canada.

Abstract
in English, French

This document updates the previous AMMI Canada Foundation Guidance (2013) on the use of antiviral therapy for influenza.

Le présent document est une mise à jour des précédentes directives d’AMMI Canada (2013) sur l’utilisation des antiviraux contre la grippe.

Keywords: antivirals; guidelines; influenza.